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The natural history of abdominal aortic
aneurysms (AAAs) is to enlarge and rupture.
Numerous investigations have shown that the mean
rate of aneurysm enlargement is between 2.6 and
6.3 mm/y.1-4 However, there is a great variability in
individual expansion rate, with up to 50% of
aneurysms showing no change over periods of time.
Individual rates vary from 0 to 10 mm/y.
Endovascular aneurysm repair (EVR) is expected
to modify this progression, and at this time, the nat-
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Objective: Untreated abdominal aortic aneurysms (AAAs) enlarge at a mean rate of 3.9
mm/y with great individual variability. We sought to determine the effect of endovas-
cular repair on the rate of change in aneurysm size.
Methods: There were 110 patients who underwent endovascular AAA repair at Stanford
University Medical Center and who were followed up for 1 to 30 months (mean, 10
months) with serial contrast-infused helical computed tomography (CT). Maximal
aneurysm diameter was determined using two independent methods: (1) measured man-
ually, from cross-sectional computed tomography (XSCT) angiograms and (2) calculat-
ed from quantitative three-dimensional computed tomography (3DCT) data as ortho-
normal diameter.
Results: Maximal cross-sectional aneurysm diameter measured by hand (XSCT) and cal-
culated as orthonormal values (3DCT) correlated closely (r = 0.915; P < .001). The
XSCT-measured diameter was larger by 2.3 ± 3.75 mm (P < .001), and the 95% CI for
SE of the bias was 1.85 to 2.75 mm. Preoperative aneurysm diameter (XSCT 59.1 ± 8.4
mm; 3DCT 58.1 ± 9.3 mm) did not differ significantly from the initial postoperative
diameter. Considering all patients, XSCT diameter decreased at a rate of 0.34 ± 0.69
mm/mo, and 3DCT diameter decreased at a rate of 0.28 ± 0.79 mm/mo. Aneurysms
in patients without endoleaks had a higher rate of decrease, an XSCT diameter by 0.50
± 0.74 mm/mo, and 3DCT diameter by 0.46 ± 0.84 mm/mo. In these patients, mean
absolute decrease in diameter at 6 months was 3.4 ± 4.5 mm (XSCT) and 3.3 ± 5.9 mm
(3DCT) and at 12 months, 5.9 ± 5.7 mm (XSCT) and 5.4 ± 5.7 mm (3DCT).
Aneurysms in patients with persistent endoleaks did not change in mean XSCT diame-
ter, and 3DCT diameter increased by 0.12 ± 0.52 mm/mo (not significant). Aneurysm
diameter remained within 4 mm of original size in 68% (3DCT) to 71% (XSCT) of
patients. In one patient, aneurysm diameter increased (XSCT and 3DCT) more than 5
mm. Four patients who had a new onset endoleak had a much higher expansion rate
than those with a chronic endoleak (P < .05).
Conclusions: The rate of decrease in aneurysm size (annualized 3.4-4.1 mm/y) after
endovascular repair of AAA approximates the reported expansion rate in untreated
aneurysms. However, individual aneurysm behavior is unpredictable, and the presence
of an endoleak is unreliable in predicting changes in diameter. New onset endoleaks are
associated with an enlargement rate greater than that of untreated aneurysms. (J Vasc
Surg 2000;32:108-15.)
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ural history of AAA after EVR is inadequately
defined. A number of investigators have shown that
aneurysms after EVR decrease in diameter, and some
have shown that aneurysms with endoleak do not
decrease in size and even expand.5-7 Although small
retrograde endoleaks have not been shown to
increase the likelihood of rupture, some believe that
the presence of an endoleak constitutes failure of an
otherwise successful EVR.
The purpose of this investigation was to deter-
mine the rate of change in aneurysm diameter after
EVR in the presence and absence of endoleak and
relate it to the documented rate of change in
untreated aneurysms. We used two methods for
measuring aneurysm diameter that are based on
periodic contrast-infused helical computed tomogra-
phy (CT) scans.
PATIENTS AND METHODS
During a 3-year period, 110 consecutive patients
underwent endovascular AAA repair at Stanford
University Medical Center with a bifurcated modu-
lar AneuRx stent graft. All patients underwent pre-
operative CT angiography for quantitative assess-
ment of aneurysm morphology, except for two
patients who underwent magnetic resonance
angiography because of renal failure. Postoperative
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CT angiography was performed within the first
month, after 6 and 12 months, and once a year
thereafter. After each of these examinations, the
patients were seen in the outpatient clinic.
The CT angiography with 2.5 to 3 mm nominal
section thickness was performed using both single
and multidetector-row CT after a rapid intravenous
bolus injection of iodinated contrast material with
timed breath-held helical CT acquired during peak
opacification. During follow-up examinations, late
acquisitions (70 seconds postinjection) were added
to rule out small endoleaks. Cross-sectional comput-
ed tomography (XSCT) images were reconstructed
at 1.25 to 1.5 mm increments. All CT scans were
acquired using the same CT angiography acquisition
protocol. In addition, helical CT scans done at
Fig 1. Scatterplot (n = 274) showing the maximal transverse diameter of the aneurysm by manual axial
measurement (XSCT) and 3-D orthonormal values (3DCT). The values were highly correlated 
(r = 0.915; P < .001), and 83.2% of the values were within 5 mm of each other. The XSCT was larg-
er by 2.3 ± 3.75 mm (P < .001), and the 95% limits of agreement were –5.2 to 9.8 mm. The 95% CI
for the SE of the bias was 1.85 to 2.75 mm.8
Table I. Direction of change of cross-sectional
diameter (XSCT) in patients with radiologic follow-
up of 3 months or longer
Endoleak No endoleak
Increase (≥ 5 mm) 4.5% (1) 0% (0)
No change (± 4 mm) 91% (20) 63% (32)
Decrease (≥ 5 mm) 4.5% (1) 37% (19)
Total 22 51
Stanford University Hospital were processed with
three-dimensional (3-D) reconstruction, which
included shaded surface display, maximal intensity
projection, and curved planar reformation.
Measurements of the orthonormal maximal diame-
ter were performed by a radiologist by constructing
a median centerline through the lumen and measur-
ing the transverse aortic diameter in a plane perpen-
dicular to it. Manual measurements of the maximal
diameter were performed by the surgeons on CT
cross sections and related to the length scale on the
film. On preoperative scans, the amount of throm-
bus within the aneurysm was graded on a discrete
scale of 1 to 3 according to subjective impression of
minimal, moderate, or large amount of thrombus
seen on multiple scan sections. On follow-up CT
scans, the presence or absence of endoleaks was
determined by a senior radiologist and reviewed by
a panel of radiologists and vascular surgeons.
Aneurysm size was related to the state of endoleak,
which was defined as positive if it persisted beyond
the first postoperative month and was present for
most of the patient’s follow-up. In four patients a
late new endoleak appeared 9 to 12 months after the
procedure, and in one patient an endoleak stopped
after 12 months. In these five patients, the follow-up
period was divided into two separate periods and
evaluated separately.
Statistical analysis included the χ2 test, paired
and unpaired t test, calculation of Pearson correla-
tion coefficient, and analysis of agreement according
to Bland and Altman.8 A P value less than .05 was
considered significant.
RESULTS
A total of 108 preoperative and 297 follow-up
helical CT scans were performed on 110 patients.
Mean follow-up was 10 months (range, 1-30
months), median follow-up was 9 months, and 37
patients had a follow-up of at least 1 year. The 3-D
reconstruction was performed on 69 preoperative
and 222 follow-up scans on 68% of the patients. The
first postoperative CT scan was performed within 48
hours in 65% of patients, within 1 week in 84% of
patients, and within 1 month in all patients. Maximal
aneurysm diameter on cross-sectional CT (XSCT)
and three-dimensional computed tomography
(3DCT), including all studies, correlated closely (r =
0.915; P < .001) (Fig 1). The XSCT-measured
diameter was larger by 2.3 ± 3.75 mm (P < .001),
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Fig 2. Scatterplot of change in the cross-sectional maximal diameter of the aneurysm (XSCT) after
EVR in patients with clinical follow-up of 3 months (n = 77). The empty triangles represent patients
with persistent endoleak (n = 22), and the black triangles represent patients without endoleak (n = 55).
There is a wide dispersion of rates for the entire group. The graph for the orthonormal values (3DCT)
exhibited similar variability. For patients with a chronic endoleak there was no linear change with time.
For those without an endoleak such correlation was found (r = 0.321; P = .017).
the 95% limits of agreement were –5.2 to 9.8 mm,
and 83.2% of measurements were within 5 mm of
each other. The 95% CI for the SE of the bias was
1.85 to 2.75 mm.8
The preoperative maximal diameter was 59.1 ±
8.4 mm on XSCT and 58.1 ± 9.3 mm on 3DCT,
and the initial postoperative values for the maximal
diameter were not different from the preoperative
values. After EVR, the mean absolute decrease in
diameter at 6 months was 2.4 ± 4.2 mm (XSCT) and
2.8 ± 5.2 mm (3DCT), and at 12 months it was 4.5
± 5.4 mm (XSCT) and 4.2 ± 5.8 mm (3DCT). The
mean overall rate of decrease in aneurysm diameter
was 0.34 ± 0.69 mm/mo on XSCT and 0.28 ± 0.79
mm/mo on 3DCT with considerable individual
variability in the rate of change (Fig 2).
Our policy with regard to endoleaks has been to
investigate and treat those that appear to be related
to the graft or the attachment sites (Type 1) and
observe those that are related to branch vessel retro-
grade flow (Type 2) unless associated with increas-
ing size. Although we did not investigate every
endoleak with arteriography, whenever CT or
duplex ultrasound scanning was suggestive of an
endoleak originating in the graft or at the attach-
ment sites, we investigated and treated it. During
follow-up, 13 patients underwent arteriography and
treatment of an endoleak. One chronic endoleak was
treated because of an increase in size.
In the absence of endoleak, aneurysm diameter
decreased on XSCT at a mean rate of 0.50 ± 0.74
mm/mo and on 3DCT by 0.46 ± 0.84 mm/mo.
The mean absolute decrease at 6 months was 3.4 ±
4.5 mm (XSCT) and 3.3 ± 5.9 mm (3DCT), and at
12 months it was 5.9 ± 5.7 mm (XSCT) and 5.4 ±
5.7 mm (3DCT). Among patients without an
endoleak, the aneurysm diameter decreased by 5
mm or more in 37% (XSCT) and 38% (3DCT)
(Tables I and II). No patient without an endoleak
had an increase in aneurysm size.
There were 22 patients with a more than 3-
month radiologic follow-up and a chronic endoleak.
In four of these, the endoleak was shown to be Type
1; in 18 others the endoleak was probably unrelated
to the graft or attachment sites. In the presence of
chronic endoleak, both the axial diameter and 3-D
orthonormal diameter remained unchanged (–0.04
± 0.33 mm/mo and 0.12 ± 0.52 mm/mo, both not
significant). This is in contrast to patients without
endoleak who had a decrease in axial diameter (P <
.001, 95% CI for difference of means 0.28-0.77
mm/mo) and 3-D orthonormal diameter (P < .05,
95% CI for difference of means 0.12-1.03 mm/mo)
compared with patients with endoleak. The rate of
change was unrelated to the initial size of the
aneurysm or to the amount of preoperative throm-
bus within it. In most patients with an endoleak, the
aneurysm diameter (91% XSCT, 81% 3DCT)
remained within 4 mm of preoperative and initial
postoperative diameter. In one patient (XSCT) and
in two patients (3DCT), the aneurysm diameter
decreased by 5 mm or more, and in one patient
(XSCT and 3DCT) it increased in size by 6 mm
compared with the initial postoperative scan.
Four patients in this series had a late endoleak:
two were symptomatic, and two were identified on
routine follow-up. The diameters of the two symp-
tomatic patients decreased significantly (by 10 and
16 mm) before the onset on the endoleak. After its
onset, expansion occurred by 16 mm over 20 days
and by 10 mm over 10 days, and both returned to
preoperative size. In one asymptomatic patient,
expansion occurred by 10 mm over 6 months since
the last examination to a size 9 mm greater than the
preoperative one, and the fourth patient presented
at the same size as the immediate postoperative test
without documentation between these time points.
The rate of increase under these circumstances may
be between 1.7 mm/mo and 1 mm/d and is signif-
icantly higher than in patients with persistent
endoleaks (P < .05).
DISCUSSION
The purpose of EVR of AAA is to modify the
natural history of AAA and prevent rupture-associat-
ed mortality. Absence of an endoleak and decrease in
aneurysm size are considered to be evidence of suc-
cessful and effective repair. We have shown that after
EVR, the aneurysm diameter decreases at a mean
rate of 0.28 to 0.34 mm/mo, according to two dif-
ferent methods of measurement. Patients without
evidence of an endoleak experience a decrease in
aneurysm size, which is significantly greater than in
patients with an endoleak.5-7
In patients without endoleaks, the rate of
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Table II. Direction of change in orthonormal diam-
eter (3DCT) in patients with radiologic follow-up of
3 months or longer
Endoleak No endoleak
Increase (≥ 5 mm) 6% (1) 0% (0)
No change (± 4 mm) 81% (13) 62% (21)
Decrease (≥ 5 mm) 12% (2) 38% (13)
Total 16 34
decrease in the mean aneurysm diameter was 0.46 to
0.50 mm/mo, similar to the rate of 0.41 to 0.44
mm/mo observed by the Utrecht and the Malmö
groups.6,9 This rate was unrelated to the amount of
preoperative thrombus, as reported by Matsumura
et al10; was unrelated to initial aneurysm size; and
did not appear to stop after 18 months as suggested
by Malina et al.11 However, the rates were individu-
ally variable, and more than half the aneurysms did
not decrease in size at all. The reasons for this vari-
ability after EVR are unclear. This is reminiscent of
the variable expansion rate of untreated AAA, where
the mean expansion rate is well documented but
individual aneurysm behavior is quite unpredictable,
and 24% or more of aneurysms do not expand at all
for prolonged periods of time.4 Although it has been
shown that an absence of endoleak is associated with
reduction in the pulsatile wall motion of the
aneurysm sac,11 experimental data from dogs
showed that closure of an endoleak by coil
embolization and thrombosis was not associated
with a reduction of pressure within the aneurysm
sac.12 Whether this individual variability after
endovascular exclusion is related to characteristics of
the aneurysm or to the degree of pressure reduction
within the aneurysm sac remains to be evaluated.
In patients with endoleaks, the mean cross-
sectional diameter (XSCT) and the mean orthonormal
diameter (3DCT) did not change significantly. This
was significantly different from those without an
endoleak but also clearly different from the enlarge-
ment one observes in untreated aneurysms. In this
respect it is clear that even in patients with an
endoleak, aneurysm behavior, on average, has been
modified, as observed also by Matsumura and
Moore.13 However, the follow-up period in this study
is short, and additional data will be acquired with time.
Different types of endoleaks may vary in clinical
significance. Although we did not investigate every
endoleak, our impression is that most chronic
endoleaks (70%-80%) were related to branch vessel
retrograde perfusion (Type 2). In patients with
endoleaks, individual aneurysm behavior varied con-
siderably. Most of these aneurysms remained
unchanged, whereas a minority decreased or
increased in size. Although it appears that aneurysms
with endoleaks that decrease in size are protected
and those that increase in size require treatment, the
dilemma lies with those aneurysms with an endoleak
that remains stationary. How do these aneurysms
differ from untreated ones? How do they differ from
the large proportion of aneurysms after EVR with-
out an endoleak that do not decrease in size? Until
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direct assessment of pressure within the aneurysm
sac becomes feasible, these issues will remain conjec-
tural. Currently, aneurysm size remains the best
guide for identifying those patients after EVR who
need evaluation and consideration of further thera-
peutic intervention.
Late onset Type 1 endoleaks may induce very
rapid aneurysm expansion. When this occurs after a
significant decrease in aneurysm size, reexpansion to
baseline size takes place. This implies that true
remodeling of the aneurysm sac does not occur and
that the structural components of the aneurysm wall
retain their original size.
In this study we compared two different
methodologies, the manual measurement from
cross-sectional CT film (XSCT) and orthonormal
measurement from 3-D reconstruction (3DCT).
Although the orthonormal measurement has a sig-
nificant theoretical advantage because it is less affect-
ed by changes in aortic tortuosity and angulation, it
is technician dependent. Software has been devel-
oped to calculate orthonormal diameter automati-
cally, free of observer interaction, but currently, it is
not widely available.14 We found here that the man-
ually measured and 3-D derived values were rough-
ly equivalent. The small but significant difference
between the two may be related to obliquity in some
of the manual measurements or to differences in
defining the outer edge of the aortic wall.
We conclude that after EVR of AAA, aneurysms
decrease in diameter at an overall rate of 4 mm/y.
Aneurysms in patients without evidence of endoleak
decrease at a rate of 6 mm/y, and most aneurysms in
patients with chronic Type 2 endoleaks do not
change in size. However, individual aneurysm
behavior is unpredictable, and the presence or
absence of an endoleak is not consistently reliable in
predicting changes in diameter. Monitoring changes
in aneurysm size may be more important.
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Dr Victor Bernhard (Palisade, Colo). The change in
aneurysm morphology after endovascular repair is an issue of
major importance for the development of appropriate fol-
low-up regimens for patients managed by this form of ther-
apy. Dr Wolf and his colleagues have clearly demonstrated
that progressive enlargement of the aneurysm is halted after
deployment of an endograft, that diameter reduction is
greater and occurs more often if the AAA is effectively
excluded from the circulation, and that failure to achieve
exclusion is associated with either no change or an increase
in cross section measurements. They have further demon-
strated that these trends are not absolutely consistent.
Reduction in diameter does not always occur and on occa-
sion may increase when postoperative imaging appears to
indicate effective exclusion. Persistent endoleak is not always
associated with an increase in diameter, and the diameter in
some instances may decrease in the presence of an endoleak.
These findings confirm the investigations of others and pro-
vide additional information that supports our understanding
or misunderstanding of the natural history of AAA after
endograft therapy. The data presented in this study also
emphasize the shortcomings of current postoperative imag-
ing techniques employed to demonstrate the presence and
source of endoleaks and strongly suggest that we cannot rely
entirely on a search for endoleaks as the primary method for
judging the success or failure of endograft deployment in a
given patient. This problem assumes greater importance as
we become aware of an increasing number of reports of pro-
gressive AAA enlargement when repeated imaging studies
including angiography fail to demonstrate any evidence of
endoleak. Therefore, I concur with the essayists that protec-
tion against rupture may be more reliably determined by ser-
ial measurements of changes in AAA size over time.
The techniques used for aortic measurement must be
consistent and reproducible if they are to be employed for
routine follow-up. We would all agree that currently the
most accurate method for determining AAA diameter is
measurement of the slice perpendicular to the flow line at
the widest portion of the aneurysm obtained from a
multi-planar reconstruction of a spiral CT. Since this
methodology is somewhat more arduous than simple
measurements from axial projections, it is nice to know
that these two techniques were comparable in your hands.
Nevertheless, the difference between the two techniques
was greater than 5 mm in 17% of the subjects in their
study. For the individual patient this may have significant
implications regarding selection of an appropriate follow-
up management strategy. Could you provide us with the
details of how measurements were actually obtained?
Although this may appear to be nitpicking, precise
methodologies need to be prescribed if they are to
become standardized techniques that can be reliably
employed by others. For instance, were your manual axial
cross section measurements performed with calipers pos-
sibly with optical enhancement, the quick and dirty use of
a marked cardboard held against the CT scale at the side
of the image, or by electronic calibration from a digitized
image? Did you measure the largest or the smallest diam-
eter at the widest point of the aneurysm? Since, as you
noted, measurements are technician dependent, did you
make repeat measurements to determine the standard
error for intraobeserver and interobserver differences?
What size change did you require to classify aneurysms as
enlarging or diminishing, and what degree of change
would you recommend for selecting the most appropriate
follow-up management strategy?
DISCUSSION
JOURNAL OF VASCULAR SURGERY
114 Wolf et al July 2000
Did you consider other methods such as changes in
aneurysm volume for evaluating aneurysm size? The
group from Utrecht, under the guidance of Bert
Eikelboom, recently presented their findings comparing
diameter with volume determination. They found a lack of
correlation between diameter and volume changes in 37%
of their patients and recommended volume as the gold
standard. It is quite laborious to measure volume from a
spiral CT image. However, with advances in computerized
imaging technology, especially noteworthy from your
institution, volume determinations may become a practical
reality and replace diameter measurements.
How many of the endoleaks identified in your patients
were Type I or Type II, and were you able to demonstrate
a difference in the rate and extent of change in diameter
between Type I and Type II endoleaks?
Finally, the rapid expansion of aneurysm diameter in two
of your patients with late onset endoleaks is disturbing. Were
these Type I or Type II? Could you speculate, or do you
have data regarding changes in the aneurysm wall after endo-
graft exclusion that might account for this phenomenon?
The authors have presented important information
regarding the natural history of abdominal aortic
aneurysm after endograft therapy. Their study emphasizes
the need to define appropriate end points as the basis for
a lifelong surveillance regimen for all aortic endografts.
Their investigation is clearly presented, and I recommend
it for your thoughtful consideration.
I would like to thank the program committee for
offering me the opportunity to discuss this excellent and
thought-provoking manuscript.
Dr Yehuda Wolf. Dr Bernhard, thank you for your
comments and your questions. I will try to answer the
questions in order.
First of all, I would like to mention that three-dimen-
sional measurement of diameter was meant to corroborate
the findings regarding changes in aneurysm size, and actu-
al comparison and validation of the three-dimensional
measurements versus the manual or traditional way of axial
measurement would require a separate study paper dedi-
cated specifically to this end. Therefore, there are aspects
that were not discussed here.
Regarding the actual method of manual measurement,
we usually used calipers. We did not use optic magnifica-
tion. The axial diameter was measured at the largest
aneurysm cross section, and both maximal and minimal
diameter at that level was measured and recorded.
The method of measurement in the 3-D laboratory is
also important. The radiology technicians scroll up and
down the median centerline and decide where the largest
cross section is by examining it on the screen. They also
measure the largest and smallest diameter. 
When we correlated the diameters, we ran correlations
of the smallest and largest diameters, and the best correla-
tion was still the largest diameter on the axial measurement
versus the largest diameter on the three-dimensional image
even though you could intuitively think otherwise. The
problem with the axial measurement is that occasionally,
with the large diameter, you are measuring obliquity, but
sometimes aneurysms are truly oval, and the differentia-
tion is very hard.
Regarding size change, we reported here on the
threshold for size change as 3 mm. We also included the 5
mm difference in the manuscript.
With regard to volume measurements, this topic is still
open, and we are currently in the process of evaluating the
importance of volume changes, which are reported regu-
larly by the 3-D laboratory monitoring for evidence of
aneurysm progression.
Regarding the type of endoleaks, two of the 22
endoleaks in the last slide with longer follow-up appeared
to be Type I. They were not regularly investigated by
angiography, but this appeared to be the case on duplex
ultrasound and CT.
The late onset endoleaks were all major Type I
endoleaks. All of these were repaired with a reintervention
and insertion of an extender cuff. Consequently we do not
have any histology of the aneurysm wall.
Dr Robert Rutherford (Silverthorne, Colo). I have a
couple of questions. The first one has to do with the prac-
tical application of this type of data.
Can you take the data on cases without endoleak and,
having plotted them out against time with a 95% confi-
dence limit, develop something that serves as “trigger”
point for intervention, so that if a case falls outside of
those limits, it serves as an indication for intensive search
for an endoleak, and intervening to control it?
Have these data helped you with your “trigger,” or
what is your trigger? Is it a certain diameter increase, or
would the lack of a decrease after a certain length of time
serve in the same way? 
Secondly, in terms of the data presented, I would like
a little additional background data. What percent of the
total cases had an increase in diameter, and what percent
had no decrease over time, and do these correlate with the
incidence of Type I endoleak? And what was the percent
of initial and late Type I endoleaks?
Dr Wolf. First of all, I would like to say that we are still
limited in this type of evaluation by the length of follow-
up and the number of cases. Clearly this is an early study,
and with time things may declare themselves better.
As the data stand now, it appears that patients without
endoleak either remain at the same size or decrease in size,
and as far as I can tell, nobody can figure out who does what.
As indicated in the manuscript, we evaluated thrombus
size by crude grading, and change in size not related to
the thrombus content of aneurysm. This was also shown
by Matsumura et al. So we know that aneurysms can either
stay the same for a long period, up to 21⁄2 years, or decrease
in size, and so far, we have no predictor for this difference.
As for defining outliers, it is pretty clear that an
aneurysm without an endoleak that increases in size
requires some type of attention. Increases in size by more
than 5 mm, I would guess, are significant.
Dr Gregory Moneta (Portland, Ore). What happens to
the iliac arteries in patients with a tube stent graft?
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Do the iliac arteries remain the same, decrease, or
increase in caliber?
Dr Wolf. There were no tube grafts in this series. All of
these are bifurcated grafts.
Dr Moneta. In other series, do you have any idea when
they did use tube grafts?
Dr Wolf. I cannot really comment about that.
Dr Wesley Moore (Los Angeles, Calif). Dr Wolf, that
was a beautiful presentation. Since your experience and
results very much parallel our own, I agree with your con-
clusions.
The reason that I rise is to ask if you have seen in your
own series a phenomenon that is now being recognized
more frequently, particularly in some of the reports from
Europe; that is, aneurysm sac enlargement in the absence
of demonstrable endoleak.
I have a couple of examples of these in my own series.
We used to believe that there must be an underlying
endoleak present, but we failed to image it. In fact, there has
now been an experience in explanting some of these in the
European experience in which they find no endoleak and
still mysteriously the aneurysm has enlarged. This has led to
a new term called “endotension.” Investigators were able to
measure an increase or a maintenance of systemic pressure
in what is seemingly a thrombosed aneurysm sac. The rea-
son for this is not clear. I wonder if you have seen this in
your own series and can speculate on the mechanism.
Dr Wolf. No, in this series we have not. I am aware of
reports by the Malmö group who measured the pulsatility
of aneurysm wall with endografts, and there are differ-
ences even if they do not have an endoleak. Also, the
Montefiore group showed that even after embolization of
endoleaks in dogs, you can still have a pressurized throm-
bus, and this conceivably can cause increase in aneurysm
diameter. In our own series, thus far, we have not seen
aneurysm enlargement without an endoleak.
